Gene targeting and cloning in pigs using fetal liver derived cells

Sanjeev K. Waghmare, Jose Estrada, Luz Reyes, Ping Li, Bess Ivary, Richard A. Sidner, Chris Burlak, A. Joseph Tector

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Since there are no pig embryonic stem cells, pig genetic engineering is done in fetal fibroblasts that remain totipotent for only 3 to 5 wk. Nuclear donor cells that remain totipotent for longer periods of time would facilitate complicated genetic engineering in pigs. The goal of this study was to test the feasibility of using fetal liver-derived cells (FLDC) to perform gene targeting, and create a genetic knockout pig. Materials and Methods: FLDC were isolated and processed using a human liver stem cell protocol. Single copy α-1,3-galactosyl transferase knockout (GTKO) FLDCs were created using electroporation and neomycin resistant colonies were screened using PCR. Homozygous GTKO cells were created through loss of heterozygosity mutations in single GTKO FLDCs. Double GTKO FLDCs were used in somatic cell nuclear transfer (SCNT) to create GTKO pigs. Results: FLDCs grew for more than 80 population doublings, maintaining normal karyotype. Gene targeting and loss of heterozygosity mutations produced homozygous GTKO FLDCs. FLDCs used in SCNT gave rise to homozygous GTKO pigs. Conclusions: FDLCs can be used in gene targeting and SCNT to produce genetically modified pigs. The increased life span in culture compared to fetal fibroblasts may facilitate genetic engineering in the pig.

Original languageEnglish
JournalJournal of Surgical Research
Volume171
Issue number2
DOIs
StatePublished - Dec 2011

Fingerprint

Gene Targeting
Transferases
Organism Cloning
Swine
Liver
Genetic Engineering
Loss of Heterozygosity
Fibroblasts
Mutation
Electroporation
Neomycin
Embryonic Stem Cells
Karyotype
Stem Cells
Polymerase Chain Reaction

Keywords

  • cloning
  • fetal liver-derived cells
  • genetic engineering
  • xenotransplantation

ASJC Scopus subject areas

  • Surgery

Cite this

Waghmare, S. K., Estrada, J., Reyes, L., Li, P., Ivary, B., Sidner, R. A., ... Tector, A. J. (2011). Gene targeting and cloning in pigs using fetal liver derived cells. Journal of Surgical Research, 171(2). https://doi.org/10.1016/j.jss.2011.07.051

Gene targeting and cloning in pigs using fetal liver derived cells. / Waghmare, Sanjeev K.; Estrada, Jose; Reyes, Luz; Li, Ping; Ivary, Bess; Sidner, Richard A.; Burlak, Chris; Tector, A. Joseph.

In: Journal of Surgical Research, Vol. 171, No. 2, 12.2011.

Research output: Contribution to journalArticle

Waghmare, SK, Estrada, J, Reyes, L, Li, P, Ivary, B, Sidner, RA, Burlak, C & Tector, AJ 2011, 'Gene targeting and cloning in pigs using fetal liver derived cells', Journal of Surgical Research, vol. 171, no. 2. https://doi.org/10.1016/j.jss.2011.07.051
Waghmare, Sanjeev K. ; Estrada, Jose ; Reyes, Luz ; Li, Ping ; Ivary, Bess ; Sidner, Richard A. ; Burlak, Chris ; Tector, A. Joseph. / Gene targeting and cloning in pigs using fetal liver derived cells. In: Journal of Surgical Research. 2011 ; Vol. 171, No. 2.
@article{f09f040d54314ef8b48035d03ee83df2,
title = "Gene targeting and cloning in pigs using fetal liver derived cells",
abstract = "Background: Since there are no pig embryonic stem cells, pig genetic engineering is done in fetal fibroblasts that remain totipotent for only 3 to 5 wk. Nuclear donor cells that remain totipotent for longer periods of time would facilitate complicated genetic engineering in pigs. The goal of this study was to test the feasibility of using fetal liver-derived cells (FLDC) to perform gene targeting, and create a genetic knockout pig. Materials and Methods: FLDC were isolated and processed using a human liver stem cell protocol. Single copy α-1,3-galactosyl transferase knockout (GTKO) FLDCs were created using electroporation and neomycin resistant colonies were screened using PCR. Homozygous GTKO cells were created through loss of heterozygosity mutations in single GTKO FLDCs. Double GTKO FLDCs were used in somatic cell nuclear transfer (SCNT) to create GTKO pigs. Results: FLDCs grew for more than 80 population doublings, maintaining normal karyotype. Gene targeting and loss of heterozygosity mutations produced homozygous GTKO FLDCs. FLDCs used in SCNT gave rise to homozygous GTKO pigs. Conclusions: FDLCs can be used in gene targeting and SCNT to produce genetically modified pigs. The increased life span in culture compared to fetal fibroblasts may facilitate genetic engineering in the pig.",
keywords = "cloning, fetal liver-derived cells, genetic engineering, xenotransplantation",
author = "Waghmare, {Sanjeev K.} and Jose Estrada and Luz Reyes and Ping Li and Bess Ivary and Sidner, {Richard A.} and Chris Burlak and Tector, {A. Joseph}",
year = "2011",
month = "12",
doi = "10.1016/j.jss.2011.07.051",
language = "English",
volume = "171",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Gene targeting and cloning in pigs using fetal liver derived cells

AU - Waghmare, Sanjeev K.

AU - Estrada, Jose

AU - Reyes, Luz

AU - Li, Ping

AU - Ivary, Bess

AU - Sidner, Richard A.

AU - Burlak, Chris

AU - Tector, A. Joseph

PY - 2011/12

Y1 - 2011/12

N2 - Background: Since there are no pig embryonic stem cells, pig genetic engineering is done in fetal fibroblasts that remain totipotent for only 3 to 5 wk. Nuclear donor cells that remain totipotent for longer periods of time would facilitate complicated genetic engineering in pigs. The goal of this study was to test the feasibility of using fetal liver-derived cells (FLDC) to perform gene targeting, and create a genetic knockout pig. Materials and Methods: FLDC were isolated and processed using a human liver stem cell protocol. Single copy α-1,3-galactosyl transferase knockout (GTKO) FLDCs were created using electroporation and neomycin resistant colonies were screened using PCR. Homozygous GTKO cells were created through loss of heterozygosity mutations in single GTKO FLDCs. Double GTKO FLDCs were used in somatic cell nuclear transfer (SCNT) to create GTKO pigs. Results: FLDCs grew for more than 80 population doublings, maintaining normal karyotype. Gene targeting and loss of heterozygosity mutations produced homozygous GTKO FLDCs. FLDCs used in SCNT gave rise to homozygous GTKO pigs. Conclusions: FDLCs can be used in gene targeting and SCNT to produce genetically modified pigs. The increased life span in culture compared to fetal fibroblasts may facilitate genetic engineering in the pig.

AB - Background: Since there are no pig embryonic stem cells, pig genetic engineering is done in fetal fibroblasts that remain totipotent for only 3 to 5 wk. Nuclear donor cells that remain totipotent for longer periods of time would facilitate complicated genetic engineering in pigs. The goal of this study was to test the feasibility of using fetal liver-derived cells (FLDC) to perform gene targeting, and create a genetic knockout pig. Materials and Methods: FLDC were isolated and processed using a human liver stem cell protocol. Single copy α-1,3-galactosyl transferase knockout (GTKO) FLDCs were created using electroporation and neomycin resistant colonies were screened using PCR. Homozygous GTKO cells were created through loss of heterozygosity mutations in single GTKO FLDCs. Double GTKO FLDCs were used in somatic cell nuclear transfer (SCNT) to create GTKO pigs. Results: FLDCs grew for more than 80 population doublings, maintaining normal karyotype. Gene targeting and loss of heterozygosity mutations produced homozygous GTKO FLDCs. FLDCs used in SCNT gave rise to homozygous GTKO pigs. Conclusions: FDLCs can be used in gene targeting and SCNT to produce genetically modified pigs. The increased life span in culture compared to fetal fibroblasts may facilitate genetic engineering in the pig.

KW - cloning

KW - fetal liver-derived cells

KW - genetic engineering

KW - xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=81155148262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155148262&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2011.07.051

DO - 10.1016/j.jss.2011.07.051

M3 - Article

VL - 171

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -